{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:23:23Z","timestamp":1740137003347,"version":"3.37.3"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Artif Organs"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s10047-022-01337-0","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T15:02:52Z","timestamp":1652713372000},"page":"79-83","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Increased risk of purge system malfunction after Impella 5.0 replacement: a case series"],"prefix":"10.1007","volume":"26","author":[{"given":"Hideo","family":"Oishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0931-3188","authenticated-orcid":false,"given":"Ryota","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Kazama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasuku","family":"Kuwayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Hiraiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Mutsuga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Usui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyoaki","family":"Murohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,16]]},"reference":[{"key":"1337_CR1","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/IMI.0000000000000535","volume":"13","author":"G Batsides","year":"2018","unstructured":"Batsides G, Massaro J, Cheung A, Soltesz E, Ramzy D, Anderson MB. Outcomes of Impella 5.0 in cardiogenic shock: a systematic review and meta-analysis. Innovations (Phila). 2018;13:254\u201360.","journal-title":"Innovations (Phila)"},{"key":"1337_CR2","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/aor.12529","volume":"39","author":"D Schibilsky","year":"2015","unstructured":"Schibilsky D, Lausberg H, Haller C, Lenglinger M, Woernle B, Haeberle H, Rosenberger P, Walker T, Schlensak C. Impella 5.0 support in INTERMACS II cardiogenic shock patients using right and left axillary artery access. Artif Organs. 2015;39:660\u20133.","journal-title":"Artif Organs"},{"key":"1337_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13019-020-01251-7","volume":"15","author":"S Tarabichi","year":"2020","unstructured":"Tarabichi S, Ikegami H, Russo MJ, Lee LY, Lemaire A. The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock. J Cardiothorac Surg. 2020;15:1\u20135.","journal-title":"J Cardiothorac Surg"},{"key":"1337_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/jocs.13978","volume":"34","author":"L Bertoglio","year":"2019","unstructured":"Bertoglio L, Katsarou M, Scandroglio M, Bertoldi L, Chiesa R, Pappalardo F. Surgical transaxillary placement of the Impella 5.0 ventricular assist device. J Card Surg. 2019;34:92\u20138.","journal-title":"J Card Surg"},{"key":"1337_CR5","first-page":"1","volume":"48","author":"DW Nelson","year":"2021","unstructured":"Nelson DW, Sundararajan S, Klein E, Joyce LD, Durham LA, Joyce DL, Mohammed AA. Sustained use of the Impella 5.0 heart pump enables bridge to clinical decisions in 34 patients. Texas Hear Inst J. 2021;48:1\u20138.","journal-title":"Texas Hear Inst J"},{"key":"1337_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/2048872616633877","volume":"6","author":"C Mastroianni","year":"2017","unstructured":"Mastroianni C, Bouabdallaoui N, Leprince P, Lebreton G. Short-term mechanical circulatory support with the Impella 5.0 device for cardiogenic shock at La Piti\u00e9-Salp\u00eatri\u00e8re. Eur Hear J Acute Cardiovasc Care. 2017;6:87\u201392.","journal-title":"Eur Hear J Acute Cardiovasc Care"},{"key":"1337_CR7","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.amjcard.2016.02.038","volume":"117","author":"B Lima","year":"2016","unstructured":"Lima B, Kale P, Gonzalez-Stawinski GV, Kuiper JJ, Carey S, Hall SA. Effectiveness and safety of the impella 5.0 as a bridge to cardiac transplantation or durable left ventricular assist device. Am J Cardiol. 2016;117:1622\u20138.","journal-title":"Am J Cardiol"},{"key":"1337_CR8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/ccd.27416","volume":"91","author":"DM Arnett","year":"2018","unstructured":"Arnett DM, Lee JC, Harms MA, Kearney KE, Ramos M, Smith BM, Anderson EC, Tayal R, McCabe JM. Caliber and fitness of the axillary artery as a conduit for large-bore cardiovascular procedures. Catheter Cardiovasc Interv. 2018;91:150\u20136.","journal-title":"Catheter Cardiovasc Interv"},{"key":"1337_CR9","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1002\/ccr3.3226","volume":"8","author":"A Said","year":"2020","unstructured":"Said A, Sayed L. Percutaneous thrombectomy of Impella-associated iliac artery thrombosis using the FlowTriever system. Clin Case Rep. 2020;8:2645\u20139.","journal-title":"Clin Case Rep"}],"container-title":["Journal of Artificial Organs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10047-022-01337-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10047-022-01337-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10047-022-01337-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T03:07:26Z","timestamp":1677467246000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10047-022-01337-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,16]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["1337"],"URL":"https:\/\/doi.org\/10.1007\/s10047-022-01337-0","relation":{},"ISSN":["1434-7229","1619-0904"],"issn-type":[{"type":"print","value":"1434-7229"},{"type":"electronic","value":"1619-0904"}],"subject":[],"published":{"date-parts":[[2022,5,16]]},"assertion":[{"value":"19 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"To received lecture fees from Ono Yakuhin, Novartis, Otsuka, and Astrazeneca, and research grants from Ono Yakuhin, Amgen Astellas, Pfizer, Alnylam, and Alexion (not in connection with the submitted work). T.M. received lecture fees and unrestricted research grants from Bayer, Daiichi-Sankyo, Dainippon Sumitomo, Kowa, MSD, Mitsubishi Tanabe, Boehringer Ingelheim, Novartis, Pfizer, Sanofi-Aventis, Takeda, Astellas, Otsuka, and Teijin.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}